Kaiser Permanente analysis underlines importance of early identification, treatment of HIV.
Kaiser Permanente Division of Research press release
Waiting to start antiretroviral therapy (ART) can have long-term health implications for people diagnosed with HIV — specifically, increased risk of dementia in later life, according to new Kaiser Permanente research.
A study published in the journal Open Forum Infectious Diseases reported that patients treated for HIV who had a low CD4 count before they started ART were more likely to be diagnosed with dementia years later.
“The finding that delayed ART can raise the risk of age-related dementia is eye-opening,” said study co-author Craig E. Hou, MD, a neurologist with The Permanente Medical Group. “Dementia risk involves multiple factors, from lifestyle to genetics, and can be even more complex among people with chronic disease. Having more evidence about what contributes to our patients’ cognitive issues will help us better understand and prevent dementias in the future.”
Read the full press release here.
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.